Description du livre Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine. 424 pp. Englisch. N� de r�f. du vendeur 9783662521557

Plus d'informations sur ce vendeur | Contacter le vendeur

Acheter neuf

EUR 160,49

Autre devise

Ajouter au panier

Frais de port : EUR 23

De Allemagne vers Etats-Unis

Destinations, frais et d�lais

Image fournie par le vendeur

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines

Anderson, Larry J.|Graham, Barney S.

Edit� par Springer Berlin Heidelberg (2016)

ISBN 10 : 3662521555 ISBN 13 : 9783662521557

Neuf Couverture souple Quantit� disponible : > 20

impression � la demande

Vendeur :

moluna
(Greven, Allemagne)

Evaluation vendeur

Evaluation du vendeur :

Description du livre Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A comprehensive review of the available information on RSVProvides a better understanding of RSV as prerequisite for the development of effective vaccinesWritten by leading experts in their respective fieldsAlthough respiratory s. N� de r�f. du vendeur 449138496

Plus d'informations sur ce vendeur | Contacter le vendeur

Acheter neuf

EUR 136,16

Autre devise

Ajouter au panier

Frais de port : EUR 48,99

De Allemagne vers Etats-Unis

Destinations, frais et d�lais

Image fournie par le vendeur

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines

Barney S. Graham

Edit� par Springer Berlin Heidelberg (2016)

ISBN 10 : 3662521555 ISBN 13 : 9783662521557

Neuf Taschenbuch Quantit� disponible : 1

Vendeur :

AHA-BUCH GmbH
(Einbeck, Allemagne)

Evaluation vendeur

Evaluation du vendeur :

Description du livre Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine. N� de r�f. du vendeur 9783662521557

Plus d'informations sur ce vendeur | Contacter le vendeur

Acheter neuf

EUR 164,03

Autre devise

Ajouter au panier

Frais de port : EUR 32,99

De Allemagne vers Etats-Unis

Destinations, frais et d�lais

Image d'archives